To Evaluate Efficacy and Safety of Z-215 in Erosive Esophagitis
NCT02463643
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
503
Enrollment
INDUSTRY
Sponsor class
Conditions
Esophagitis, Reflux
Interventions
DRUG:
Z-215 10mg
DRUG:
Z-215 20mg
DRUG:
Z-215 Placebo
DRUG:
Rabeprazole Sodium
DRUG:
Rabeprazole Sodium Placebo
Sponsor
Zeria Pharmaceutical